Recurrence of Autoimmune Hepatitis After COVID-19 Vaccination

Abstract

A 35-year-old Asian female with a pertinent past medical history of autoimmune hepatitis presented with an acute recurrence of autoimmune hepatitis two weeks after receiving the second dose of the Pfizer-BioNTech messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccine. Nine cases of autoimmune hepatitis after the administration of the COVID-19 vaccine have been reported, but this is the first documented case of a reactivation of autoimmune hepatitis in remission. As recommendations for COVID-19 vaccinations and booster shots continue to evolve, all adverse events should be reported to better educate and monitor patients.